Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®

109 0

IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV)
Antibody levels remained high after twelve months in … [+11239 chars]
Read Full Story

Fintech industry divided over regulatory environment – CBN

Posted by Publisher - February 2, 2026 0

Nigerias fintech industry is evenly divided over the countrys regulatory climate, with half of operators describing it as supportive of…

Posted by Publisher - May 9, 2026 0

Here is my interview on the Kianistan podcast with Tafheem Kiani about the ongoing Israeli-US-Iran War. Kianistan Podcast: USA War…

Posted by Publisher - January 15, 2026 0

RABAT, Jan 15 : Nigeria were drawn with Egypt, Zambia and newcomers Malawi for the defence of their Womens Africa…

Posted by Publisher - October 28, 2025 0

The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any…

Posted by Publisher - January 20, 2026 0

If you click ‘Accept all’, we and our partners, including 245 who are part of the IAB Transparency & Consent…